Hofseth BioCare ASA
Hofseth BioCare ASA
07/11/2022 | Press release | Distributed by Public on 07/11/2022 08:32
Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED
Tid11.07.2022, 14:24:01
MeldingsID566798
UtstederIDHBC
MarkedOslo Børs
Andre språk
Korrigerte versjoner
KategoriENDRINGER I RETTIGHETENE TIL AKSJER / VERDIPAPIRER
-
Informasjonspliktige opplysningerInformasjonspliktige opplysninger i henhold til lov, forskrift eller børsens egne regler for markedet verdipapiret er notert på.
-
Lagringspliktig meldingMed lagringspliktige meldinger menes meldinger som skal oppbevares i offisiell lagringsmekanisme (OAM) etter verdipapirhandelloven § 5-12 og/eller børsens egne regler.
Vedlegg
Del melding
Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED
Ålesund, Norway - 11 July 2022. Reference is made to the stock exchange
announcement on 3 July 2022 regarding the completion of a private placement (the
"Private Placement") in Hofseth BioCare ASA.
The share capital increase pertaining to issuance of 25,140,000 of the shares in
the Private Placement (the first resolution, as described in the stock exchange
notice published on 3 July 2022) has now been registered with the Norwegian
Register of Business. The new registered share capital of the Company is NOK
3,829,710.30 divided by 382 971 030 shares, each with a par value of NOK 0.01.
The new shares will be issued in the VPS and delivered to the investors as soon
as practically possible, whereupon the share lending agreement entered into
between Ødegård Prosjekt AS (a close associate of CFO Jon Olav Ødegård) and the
Company in connection with the Private Placement relating to 958,810 of the new
shares, also will be settled.
For further information, please contact:
Jon Olav Ødegård, CFO at HBC
Phone: +47 936 32 966
E-mail: [email protected]
This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.
announcement on 3 July 2022 regarding the completion of a private placement (the
"Private Placement") in Hofseth BioCare ASA.
The share capital increase pertaining to issuance of 25,140,000 of the shares in
the Private Placement (the first resolution, as described in the stock exchange
notice published on 3 July 2022) has now been registered with the Norwegian
Register of Business. The new registered share capital of the Company is NOK
3,829,710.30 divided by 382 971 030 shares, each with a par value of NOK 0.01.
The new shares will be issued in the VPS and delivered to the investors as soon
as practically possible, whereupon the share lending agreement entered into
between Ødegård Prosjekt AS (a close associate of CFO Jon Olav Ødegård) and the
Company in connection with the Private Placement relating to 958,810 of the new
shares, also will be settled.
For further information, please contact:
Jon Olav Ødegård, CFO at HBC
Phone: +47 936 32 966
E-mail: [email protected]
This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.